Elizabeth Gurysh, Ph.D., received a National Research Service Award from the National Institutes of Health to support her brain cancer research. Gurysh is a postdoctoral researcher working in the lab of Kristy Ainslie, Ph.D., at the UNC Eshelman School of … Read more

Researchers at the University of North Carolina at Chapel Hill are developing a universal flu vaccine which could be effective against multiple influenza strains and in multiple flu seasons. In the United States, up to 35.6 million people become infected … Read more

The National Institutes of Health awarded a grant of nearly $2 million to Kristy Ainslie, Ph.D., for a proposal to develop a therapeutic vaccine for multiple sclerosis. Ainslie is an associate professor in the Division of Pharmacoengineering and Molecular Pharmaceutics … Read more

Kristy Ainslie, Ph.D., an associate professor in the Division of Pharmacoengineering and Molecular Pharmaceutics at the UNC Eshelman School of Pharmacy, has been granted tenure. Ainslie joined the School in 2014. Prior to that, she spent almost five years as … Read more

Elizabeth Gurysh, Ph.D., was awarded the pharmaceutics postdoctoral fellowship by the PhRMA Foundation, whose mission is to support young scientists in disciplines important to the pharmaceutical industry to encourage them to pursue careers in research and education related to drug … Read more

Kristy Ainslie, PhD, joins the UNC Eshelman School of Pharmacy as an associate professor after almost five years as an assistant professor at Ohio State. Ainslie’s research focuses on immune therapies, including bioterrorism vaccines, autoimmune treatments, and host cell-directed therapeutics. … Read more